Jason S. Knight/X
Jul 31, 2025, 16:43
Jason S Knight: Antiphospholipid Syndrome Review
Jason S Knight, Professor at University of Michigan Medical School, shared a post on X:
“ICYMI, our review article about antiphospholipid syndrome in ACR Journals is now nicely formatted (and remains free)
Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities․”
Title: Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities
Authors: Thalia G. Newman, Jason S. Knight
Read the full article here.
Stay updated on the latest scientific advancements in the filed with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy